c-Abl: activation and nuclear targets - PubMed (original) (raw)
Review
c-Abl: activation and nuclear targets
Y Shaul. Cell Death Differ. 2000 Jan.
Abstract
The c-Abl tyrosine kinase and its transforming variants have been implicated in tumorigenesis and in many important cellular processes. c-Abl is localized in the nucleus and the cytoplasm, where it plays distinct roles. The effects of c-Abl are mediated by multiple protein-protein and protein-DNA interactions and its tyrosine kinase domain. At the biochemical level, the mechanism of c-Abl kinase activation and the identification of its target proteins and cellular machineries have in part been solved. However, the phenotypic outcomes of these molecular events remained in large elusive. c-Abl has been shown to regulate the cell cycle and to induce under certain conditions cell growth arrest and apoptosis. In this respect the interaction of c-Abl with p53 and p73 has attracted particular attention. Recent findings have implicated c-Abl in an ionizing irradiation signaling pathway that elicits apoptosis. In this pathway p73 is an important immediate downstream effector. Here I review the current knowledge about these nuclear processes in which c-Abl is engaged and discuss some of their possible implications on cell physiology. Cell Death and Differentiation (2000) 7, 10 - 16.
Similar articles
- Role of c-Abl in the DNA damage stress response.
Shaul Y, Ben-Yehoyada M. Shaul Y, et al. Cell Res. 2005 Jan;15(1):33-5. doi: 10.1038/sj.cr.7290261. Cell Res. 2005. PMID: 15686624 Review. - p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
Goga A, Liu X, Hambuch TM, Senechal K, Major E, Berk AJ, Witte ON, Sawyers CL. Goga A, et al. Oncogene. 1995 Aug 17;11(4):791-9. Oncogene. 1995. PMID: 7651743 - Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion.
Kain KH, Gooch S, Klemke RL. Kain KH, et al. Oncogene. 2003 Sep 4;22(38):6071-80. doi: 10.1038/sj.onc.1206930. Oncogene. 2003. PMID: 12955086 - JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage.
Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y. Yoshida K, et al. Nat Cell Biol. 2005 Mar;7(3):278-85. doi: 10.1038/ncb1228. Nat Cell Biol. 2005. PMID: 15696159 - DNA damage stress response in germ cells: role of c-Abl and clinical implications.
Gonfloni S. Gonfloni S. Oncogene. 2010 Nov 25;29(47):6193-202. doi: 10.1038/onc.2010.410. Epub 2010 Sep 6. Oncogene. 2010. PMID: 20818431 Review.
Cited by
- ABL1-mediated phosphorylation promotes FOXM1-related tumorigenicity by Increasing FOXM1 stability.
Dong Q, Wang D, Song C, Gong C, Liu Y, Zhou X, Yue J, Hu Y, Liu H, Zhu L, Niu X, Zheng T, Zhang X, Jin J, Wang T, Ju R, Wang C, Jiang Q, Gao T, Jin Y, Li P, Wang Y, Zhang C, Wang GF, Cao C, Liu X. Dong Q, et al. Cell Death Differ. 2024 Oct;31(10):1285-1301. doi: 10.1038/s41418-024-01339-w. Epub 2024 Jul 26. Cell Death Differ. 2024. PMID: 39060421 Free PMC article. - A single amino acid in the Salmonella effector SarA/SteE triggers supraphysiological activation of STAT3 for anti-inflammatory target gene expression.
Gaggioli MR, Jones AG, Panagi I, Washington EJ, Loney RE, Muench JH, Brennan RG, Thurston TLM, Ko DC. Gaggioli MR, et al. bioRxiv [Preprint]. 2024 Feb 14:2024.02.14.580367. doi: 10.1101/2024.02.14.580367. bioRxiv. 2024. PMID: 38405869 Free PMC article. Preprint. - Future treatment of Diabetes - Tyrosine Kinase inhibitors.
S AK, Patel SS, Patel S, Parikh P. S AK, et al. J Diabetes Metab Disord. 2022 Dec 1;22(1):61-71. doi: 10.1007/s40200-022-01164-3. eCollection 2023 Jun. J Diabetes Metab Disord. 2022. PMID: 37255821 Free PMC article. Review. - The phosphorylation of PHF5A by TrkA-ERK1/2-ABL1 cascade regulates centrosome separation.
Song C, Zhang Y, Li Y, Bie J, Wang Z, Yang X, Li H, Zhu L, Zhang T, Chang Q, Luo J. Song C, et al. Cell Death Dis. 2023 Feb 9;14(2):98. doi: 10.1038/s41419-023-05561-1. Cell Death Dis. 2023. PMID: 36759599 Free PMC article. - Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation.
Daniels HG, Knicely BG, Miller AK, Thompson A, Plattner R, Goellner EM. Daniels HG, et al. Front Genet. 2022 Oct 20;13:940073. doi: 10.3389/fgene.2022.940073. eCollection 2022. Front Genet. 2022. PMID: 36338985 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous